Search

everythinglearnresearchcommunity

for

Search:↓

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Different types of skin fibroblasts have unique roles in skin health and disease.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

RF-based therapies might help treat hair loss.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

PRP is an effective and safe treatment for alopecia areata.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

More research is needed to find the best long-term treatments for Alopecia Areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

New cytokine-targeted therapies show promise for treating alopecia areata.

Stress hormone corticosterone suppresses hair growth by affecting stem cell activity and Gas6 protein expression.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Baricitinib is a promising treatment for alopecia areata.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.